Table 2.

Annual age-adjusteda mortality rates per 100,000 for selected cancers by race/ethnicity, New York (2008–2014: male)

Selected black subgroupsSelected Hispanic subgroups
Non-Hispanic whiteAsian/Pacific IslanderNon-Hispanic black allfU.S.-born blackCaribbean-born blackHispanic allfPuerto RicanDominicanCentral AmericanSouth American
n = 91,500n = 4,709n = 15,850n = 11,801n = 2,871n = 9,899n = 5,177n = 1,644n = 744n = 1,322
Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)
Oral cavity and pharynx3.2 (3.0–3.3)3.2 (2.6–3.8)4.3 (3.8–4.8)5.8 (5.1–6.6)1.4 (0.9–2.3)2.9 (2.5–3.4)4.9 (4.1–5.8)1.8 (1.1–2.6)1.5 (0.7–2.8)0.9 (0.4–1.6)
Esophagus7.8 (7.6–8.1)3.0 (2.5–3.6)6.1 (5.5–6.7)7.7 (6.9–8.6)3.5 (2.7–4.8)4.6 (4.1–5.1)7.2 (6.2–8.3)4.0 (2.9–5.3)2.7 (1.4–4.6)1.8 (1.1–2.8)
Stomach4.2 (4.0–4.4)9.5 (8.5–10.6)9.2 (8.5–10.0)9.5 (8.5–10.5)8.3 (7.0–9.9)7.2 (6.6–8.0)7.8 (6.7–9.0)5.2 (4.0–6.6)11.5 (8.7–14.8)7.1 (5.7–8.8)
Colorectum16.9 (16.5–17.3)12.8 (11.6–14.1)22.7 (21.5–23.9)26.7 (25.1–28.3)14.5 (12.9–16.5)15.6 (14.6–16.6)21.7 (19.9–23.6)11.2 (9.4–13.3)13.0 (10.0–16.6)11.7 (9.8–13.9)
Liverb7.2 (6.9–7.4)13.1 (11.9–14.3)13.1 (12.3–13.9)17.7 (16.6–19.0)5.1 (4.2–6.5)12.7 (11.9–13.6)21.3 (19.7–23.1)7.8 (6.3–9.5)8.5 (6.0–11.5)6.6 (5.2–8.2)
 1945–1965 birth cohortc2.7 (2.5–2.8)4.6 (4.0–5.3)6.8 (6.2–7.4)10.0 (9.1–11.0)1.7 (1.2–2.7)5.8 (5.3–6.4)11.5 (10.3–12.8)2.7 (1.9–3.7)2.5 (1.4–4.3)2.0 (1.4–2.9)
 Outside birth cohort4.5 (4.3–4.7)8.4 (7.4–9.7)6.3 (5.6–7.1)7.7 (6.7–8.9)3.4 (2.6–4.9)6.9 (6.1–7.9)9.8 (8.3–11.8)5.1 (3.8–7.3)5.9 (3.6–10.0)4.6 (3.4–6.9)
Pancreas13.7 (13.4–14.0)8.1 (7.2–9.1)13.3 (12.4–14.2)15.8 (14.6–17.0)8.2 (6.9–9.8)9.1 (8.4–9.9)10.4 (9.2–11.7)8.9 (7.3–10.8)8.8 (6.3–12.0)7.8 (6.2–9.6)
Lungd53.1 (52.5–53.8)32.5 (30.6–34.5)53.8 (52.0–55.6)73.3 (70.7–76.0)22.0 (20.0–24.4)29.2 (27.9–30.6)40.0 (37.5–42.5)24.1 (21.3–27.2)21.5 (17.2–26.4)16.7 (14.2–19.3)
Prostate17.6 (17.2–18.0)7.7 (6.7–8.8)43.4 (41.7–45.2)45.3 (43.1–47.6)36.8 (33.9–40.0)19.3 (18.1–20.6)21.6 (19.6–23.7)20.0 (17.3–23.0)29.5 (24.0–35.7)13.2 (10.9–15.9)
Kidney5.3 (5.1–5.5)2.4 (1.9–2.9)4.1 (3.7–4.7)5.0 (4.3–5.7)2.2 (1.6–3.3)2.8 (2.4–3.2)3.7 (3.0–4.5)1.3 (0.7–2.1)2.8 (1.5–4.6)2.8 (1.9–4.0)
Bladder9.1 (8.9–9.4)2.9 (2.3–3.5)5.5 (4.9–6.2)6.6 (5.8–7.5)3.8 (2.9–5.2)4.3 (3.8–4.9)5.3 (4.4–6.4)3.9 (2.8–5.3)2.5 (1.1–4.7)3.0 (2.0–4.4)
Brain5.4 (5.2–5.6)2.1 (1.7–2.6)2.7 (2.3–3.1)3.1 (2.6–3.6)2.0 (1.5–3.1)2.7 (2.4–3.2)3.1 (2.5–3.8)2.6 (1.8–3.6)2.4 (1.3–4.0)2.5 (1.8–3.5)
CUP10.1 (9.9–10.4)4.8 (4.1–5.6)10.5 (9.7–11.3)13.1 (12.0–14.2)5.6 (4.6–7.0)7.1 (6.5–7.8)9.6 (8.4–10.9)5.8 (4.5–7.4)4.8 (2.9–7.1)5.0 (3.7–6.6)
NHL7.8 (7.5–8.0)4.3 (3.6–5.0)5.8 (5.2–6.4)5.9 (5.2–6.7)5.4 (4.4–6.8)6.2 (5.6–6.9)6.8 (5.8–7.8)6.0 (4.7–7.6)6.1 (4.1–8.6)6.5 (5.0–8.2)
Myeloma3.6 (3.4–3.8)1.4 (1.0–1.9)6.5 (5.9–7.2)6.6 (5.8–7.4)6.5 (5.5–8.0)3.4 (3.0–4.0)3.4 (2.7–4.2)3.9 (2.8–5.2)3.6 (2.0–5.7)3.8 (2.7–5.2)
Leukemia9.5 (9.2–9.8)4.1 (3.5–4.8)7.0 (6.4–7.7)7.5 (6.6–8.3)6.1 (5.0–7.5)5.9 (5.3–6.5)5.5 (4.7–6.5)6.2 (4.8–7.7)5.7 (3.7–8.3)6.8 (5.3–8.6)
All-sites-combinede193.3 (192.0–194.6)120.4 (116.7–124.2)224.3 (220.6–228.0)269.5 (264.5–274.6)140.7 (135.3–146.4)146.3 (143.2–149.4)190.7 (185.2–196.2)122.8 (116.4–129.5)134.0 (123.1–145.5)106.9 (100.6–113.4)
  • Abbreviations: CUP, cancers of unknown primary; NHL, non-Hodgkin lymphoma.

  • a2000 U.S. Standard Population.

  • bIncludes intrahepatic bile duct.

  • cHigh HCV prevalence birth cohort; age-adjusted rates for liver cohorts originate from different age groups and thus should only be compared across populations, not within.

  • dIncludes bronchus.

  • eAll sites-combined includes those listed as well as those not listed here.

  • f“All” includes those who fall in this race/ethnicity category but not specifically studied here.